Back

Flecainide suppresses an arrhythmogenic substrate in Andersen-Tawil syndrome-induced pluripotent stem cell-derived cardiomyocytes

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Stem cells and cell therapy Stem cells and cell therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Yusuke Kuroda

Shizuoka Saiseikai General Hospital, Shizuoka (Japan)

9 More presentations in this session

Presentation thumbnail
Susceptibility to induced ventricular tachycardias increases with time after transplantation of induced pluripotent stem cell-derived cardiomyocytes into infarcted mouse hearts
Doctor G. Peinkofer (Cologne, DE)
Abstract
Presentation thumbnail
Atrial & ventricular cardiac progenitor cells from the same heart show differential characteristics for cardiac regeneration but are superior to the endothelial progenitor cells from the same patient
Miss P. Dixit (London, GB)
Abstract Slides Video
Presentation thumbnail
Transplantation of adipose mesenchymal cells overexpressing telomerase and myocardin preserved cardiac function and promoted tissue repair in murine myocardial infarction
Assistant Professor R. Madonna (Pisa, IT)
Abstract
Presentation thumbnail
The heart has a constant and significant cardiomyocyte replacement rate by endogenous cardiac stem cells in the adult life
Doctor E. Cianflone (Catanzaro, IT)
Abstract
Presentation thumbnail
c-kit/CreERT2 knock-in allele does not efficiently fate-track c-kit positive resident cardiac stem cells and impairs their regenerative potential
Doctor I. Aquila (Catanzaro, IT)
Abstract

Access the full session

Session thumbnail
Stem cells and cell therapy

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources